“…1,2 This stimulated many researchers toward designing drugs to block the effects of AngII either by inhibiting the angiotensin-converting enzyme (ACE) or renin or by blocking the AngII receptors. [3][4][5][6][7][8][9][10] AngII receptor antagonists have proved to lower blood pressure effectively, 11 and they are better tolerated than other classes of drugs. 12,13 Losartan, 14,15 the protypical agent of this category, was served as lead for the development of newer AngII receptor antagonists.…”